Abstract
Pivotal Phase 2 Study of the EZH1 and EZH2 Inhibitor Valemetostat Tosylate (DS-3201b) in Patients with Relapsed or Refractory Adult T-Cell Leukemia/Lymphoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have